Curative Biotechnology Inc | Business Finance | Business Contracts

Seventh Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on January 25, 2023)

Seventh Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on January 13, 2023)

Sixth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on January 9, 2023)

Second Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)

Third Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)

Fourth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)

Fifth Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 30, 2022)

Form of Underwriting Agreement (Filed With SEC on November 7, 2022)

Specimen of Common Stock Certificate (Filed With SEC on November 7, 2022)

Specimen Series A Preferred Stock (Filed With SEC on November 7, 2022)

Specimen of Series B Preferred Stock (Filed With SEC on November 7, 2022)

Specimen of Series C Preferred Stock (Filed With SEC on November 7, 2022)

Form of Common Stock Purchase Warrant issued to Certain Consultants in May 2021 (Filed With SEC on November 7, 2022)

Form of Common Stock Purchase Warrant issued to Investors in August 2021 (Filed With SEC on November 7, 2022)

Form of Warrant issued to investors on May 21, 2021 (Filed With SEC on November 7, 2022)

Form of Warrant issued to Investors in Note Offering from November 2020 through January 2021 (Filed With SEC on November 7, 2022)

Form of Common Stock Purchase warrant issued to Consultant on December 3, 2020 (Filed With SEC on November 7, 2022)

Form of Common Stock Purchase Warrant issued to Paul Michaels on June 11, 2021 (Filed With SEC on November 7, 2022)

Form of Common Stock Purchase Warrant issued to Marc Drimer on July 14, 2021 (Filed With SEC on November 7, 2022)

Form of Common Stock Purchase Option issued to Catherine Sohn pursuant to Consulting Agreement dated September 27, 2021 (Filed With SEC on November 7, 2022)

Form of Underwriter Warrant (Filed With SEC on November 7, 2022)

Form of warrant to be issued in Underwritten Offering (Filed With SEC on November 7, 2022)

Form of Subscription Agreement for Investor Offerings in August 2021 (Filed With SEC on November 7, 2022)

Form of Subscription Agreement for Investor Offerings on May 21, 2021 (Filed With SEC on November 7, 2022)

Form of Note Issued to Investors between November 2020 and January 2021 (Filed With SEC on November 7, 2022)

Exclusive Option Agreement for Purchase of Patent Rights dated September 30, 2020 between Curative Biotechnology (fka Connectyx Technologies Holdings Group) and IEM Inc (Filed With SEC on November 7, 2022)

Securities Purchase Agreement for March 2022 Offering (Filed With SEC on November 7, 2022)

Secured Convertible Promissory Note for March 2022 Offering (Filed With SEC on November 7, 2022)

Security Agreement for March 2022 Offering (Filed With SEC on November 7, 2022)

Intellectual Property Security Agreement for March 2022 Offering (Filed With SEC on November 7, 2022)

Warrant for March 2022 Offering (Filed With SEC on November 7, 2022)

Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on November 7, 2022)

Form of Warrant Agency Agreement (Filed With SEC on November 7, 2022)

Form of Common Stock Purchase Option issued to Catherine Sohn pursuant to Consulting Agreement dated September 27, 2021 (Filed With SEC on September 30, 2022)

Securities Purchase Agreement for March 2022 Offering (Filed With SEC on September 9, 2022)

Secured Convertible Promissory Note for March 2022 Offering (Filed With SEC on September 9, 2022)

Security Agreement for March 2022 Offering (Filed With SEC on September 9, 2022)

Intellectual Property Security Agreement for March 2022 Offering (Filed With SEC on September 9, 2022)

Warrant for March 2022 Offering (Filed With SEC on September 9, 2022)

Amendment to March 2022 Convertible Note Transaction Documents (Filed With SEC on September 9, 2022)

Curative Biotechnology Inc (111) | Business Finance (64)